[PHARMA] YoY Cumulative Quarter Result on 30-Jun-2018 [#2]

Announcement Date
17-Aug-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- 30.67%
YoY- -19.21%
Quarter Report
View:
Show?
Cumulative Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 1,970,622 1,465,684 1,387,998 1,200,652 1,136,261 1,090,991 984,749 12.24%
PBT 53,768 45,206 42,724 40,677 37,927 48,025 63,668 -2.77%
Tax -17,052 -13,184 -13,814 -17,322 -8,918 -13,914 -15,100 2.04%
NP 36,716 32,022 28,910 23,355 29,009 34,111 48,568 -4.55%
-
NP to SH 36,840 32,378 28,898 22,980 28,443 33,374 48,011 -4.31%
-
Tax Rate 31.71% 29.16% 32.33% 42.58% 23.51% 28.97% 23.72% -
Total Cost 1,933,906 1,433,662 1,359,088 1,177,297 1,107,252 1,056,880 936,181 12.84%
-
Net Worth 357,275 357,891 518,564 519,642 541,894 524,041 527,991 -6.29%
Dividend
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Div 30,100 22,204 22,149 23,383 20,742 23,302 36,234 -3.04%
Div Payout % 81.71% 68.58% 76.65% 101.76% 72.93% 69.82% 75.47% -
Equity
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Net Worth 357,275 357,891 518,564 519,642 541,894 524,041 527,991 -6.29%
NOSH 261,991 261,705 261,229 259,821 259,279 258,913 258,819 0.20%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 1.86% 2.18% 2.08% 1.95% 2.55% 3.13% 4.93% -
ROE 10.31% 9.05% 5.57% 4.42% 5.25% 6.37% 9.09% -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 150.58 561.06 532.65 462.11 438.24 421.37 380.48 -14.30%
EPS 2.82 12.39 11.09 8.84 10.97 12.89 18.55 -26.92%
DPS 2.30 8.50 8.50 9.00 8.00 9.00 14.00 -25.97%
NAPS 0.273 1.37 1.99 2.00 2.09 2.024 2.04 -28.45%
Adjusted Per Share Value based on latest NOSH - 259,821
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 136.73 101.69 96.30 83.31 78.84 75.70 68.33 12.24%
EPS 2.56 2.25 2.01 1.59 1.97 2.32 3.33 -4.28%
DPS 2.09 1.54 1.54 1.62 1.44 1.62 2.51 -3.00%
NAPS 0.2479 0.2483 0.3598 0.3605 0.376 0.3636 0.3663 -6.29%
Price Multiplier on Financial Quarter End Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 -
Price 5.29 2.22 2.84 2.88 4.58 5.50 7.13 -
P/RPS 3.51 0.40 0.53 0.62 1.05 1.31 1.87 11.05%
P/EPS 187.92 17.91 25.61 32.56 41.75 42.67 38.44 30.24%
EY 0.53 5.58 3.90 3.07 2.40 2.34 2.60 -23.26%
DY 0.43 3.83 2.99 3.13 1.75 1.64 1.96 -22.32%
P/NAPS 19.38 1.62 1.43 1.44 2.19 2.72 3.50 32.97%
Price Multiplier on Announcement Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 20/08/21 19/08/20 23/08/19 17/08/18 16/08/17 19/08/16 17/08/15 -
Price 0.925 4.42 2.66 3.11 4.19 5.62 5.65 -
P/RPS 0.61 0.79 0.50 0.67 0.96 1.33 1.48 -13.72%
P/EPS 32.86 35.66 23.99 35.16 38.20 43.60 30.46 1.27%
EY 3.04 2.80 4.17 2.84 2.62 2.29 3.28 -1.25%
DY 2.49 1.92 3.20 2.89 1.91 1.60 2.48 0.06%
P/NAPS 3.39 3.23 1.34 1.56 2.00 2.78 2.77 3.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment